
Ginkgo Bioworks Holdings Inc (NYSE:DNA) is trading higher in Monday's after-hours session after the company reported financial results and issued guidance above estimates.
Ginkgo Bioworks said fourth-quarter revenue increased 363% year-over-year to $148 million, which beat the $94 million estimate.